Offered by the American Chemical Society
Kristin Sainani, Clinical Assistant Professor with Health Research and Policy, Stanford University.
Thursday, February 3, 2011, 2:00-3:00 pm ET REGISTER HERE.
A public workshop will be held to examine the perceived value of genetic and genomic technologies, both present and future, in clinical practice from different stakeholder perspectives.
This workshop will build on the concepts of clinical utility, personal utility, public utility, and economic value, and explore these different types of value through questions such as:
-How do different stakeholders define the value of genetic and genomic technologies?
-How do stakeholders evaluate the weight of one kind of value in relation to another?
-How do people assess relative values to make health care decisions?
-How do these types of value relate, or not relate, to the monetary cost of the technologies?
Presentations and discussions will explore the concept of value in regards to genomics and genetics, and how it affects the view of stakeholders and the way they make decisions about using these technologies. Stakeholders, including patients, payers, policy makers, and others will present their perspectives.